About ACBM

The Association for Cognitive Bias Modification (ACBM) is committed to improving CBM research and application in a manner that reflects scientific rigour, clinical integrity, and dissemination of evidence-based assessment and therapeutics.

Mission

Consistent with this mission, the Association engages in the following three key activities:

  1. Developing guidelines and software resources to promote the adoption of reliable and valid approaches for assessing cognitive biases.
  2. Designing and evaluating methods of delivering cognitive bias modification procedures that maximise their capacity to engage their targets.
  3. Translating the resulting scientific advances into empirically-validated CBM interventions that are accessible, scalable, and sustainable within the clinical setting.

History of ACBM

A description of ACBM’s founding process, preliminary meetings in London, Washington DC, Amsterdam, and Berlin will appear soon.

Leadership

ACBM is run by a committed group of elected and unelected volunteers from the field of CBM around the world. The organization is governed by a Board of Directors consisting of 10-15 members, including a membership-elected President, the Past-President, President-Elect, Secretary, Treasurer, Science Director, Membership Secretary, Public Engagement Director, and directors at large. Every two years, ACBM holds an open election to fill expiring board terms and the President-Elect position. Board Members serve a three-year term and the President serves for two years. To secure smooth continuity in leadership, Past-, Present-, and Elect-Presidents serve together on the board. Download the Bylaws that govern ACBM.

Jennifer Lau, PhD

President

Board Term 2026-2027

Professor Jennifer Lau is a Professor of Youth Resilience and Co-Centre Lead of Psychiatry and Mental Health at the Wolfson Institute of Population Health, Queen Mary University of London. Her research focuses on the development and early intervention of mood, anxiety and loneliness problems in young people, with a particular emphasis on the role of cognitive factors such as interpretation biases and mental imagery. As a leading voice in youth resilience, she co-directs the Youth Resilience Unit and leads the Social Health Hub, where she works to translate basic science into targeted, co-produced interventions for emotional difficulties. Jennifer brings extensive expertise in interdisciplinary research and a deep commitment to bridging the gap between clinical theory, experimental science, and real-world application. She is dedicated to advancing the mission of the Association for Cognitive Bias Modification (ACBM) by fostering collaborative research that improves the psychological wellbeing of young people and the wider community.

Eni Becker, PhD

Immediate Past President

Board Term 2026-2027

Professor Eni S. Becker is the Chair of Clinical Psychology at Radboud University, The Netherlands, focusing on cognitive processes and their role in psychopathology, with a specific interest in anxiety and affective disorders. Her passion for bridging the gap between fundamental and applied research in clinical psychology is evident in her work. She firmly believes that CBM is an essential tool in achieving this goal. Eni brings a wealth of experience, enthusiasm, and a strong team spirit that fosters critical discourse and interdisciplinary collaboration. She is committed to leveraging her expertise to drive ACBM’s mission to promote and advance the field of cognitive bias modification towards better research, ultimately benefiting patients.

Board

Jeremy Pettit, PhD

President Elect

Board Term 2026-2027

Julian Basanovic, PhD

Secretary

Board Term 2025-2027

Mike Rinck, PhD

Treasurer

Board Term 2026-2028

Victoria Manning, PhD

Science Director

Board Term 2026-2027

Charlotte Wittekind, PhD

Membership Secretary

Board Term 2026-2027

Julie Ji, PhD

Public Engagement Director

Board Term 2026-2027

Amit Lazarov, PhD

General Director

Board Term 2026-2027

Reut Naim, PhD

General Director

Board Term 2026-2027

Hadas Okon-Singer, PhD

General Director

Board Term 2026-2027

Yair-Bar Haim, PhD

Co-opted General Director

Board Term 2026-2027

Nilly Mor, PhD

Co-opted General Director

Board Term 2025-2026

Daniel S. Pine, MD

Co-opted General Director

Board Term 2026-2027

Colin MacLeod, PhD​

Co-opted General Director

Board Term 2026-2027

Advisory Roles

Ali Khatibi, PhD

Reinout Wiers, PhD

Elske Salemink, PhD

Marcella Woud, PhD

Scroll to Top